Independent Ethics Committee (IEC)

An Independent Ethics Committee (IEC) is the term used internationally — and by the ICH E6 Good Clinical Practice guideline itself — for the independent review body that performs, outside the United States, the same function a US Institutional Review Board (IRB) performs domestically: reviewing and approving a trial protocol, informed consent process and materials, investigator qualifications, and trial facilities before enrollment, and providing continuing review through the life of the study, in order to protect the rights, safety, and wellbeing of participants.

IRB and IEC are the same function, not two different roles

ICH E6(R2)’s glossary defines Institutional Review Board (IRB) and Independent Ethics Committee (IEC) as separate entries (Sections 1.31 and 1.27 respectively), but describes both as independent bodies constituted of medical, scientific, and non-scientific members whose responsibility is to protect trial subjects by reviewing, approving, and continuing to review the protocol, amendments, and the methods and materials used to obtain informed consent. The guideline’s own Section 3 (Institutional Review Board/Independent Ethics Committee) treats the two as interchangeable for the purposes of GCP compliance — the reason the pairing ‘IRB/IEC’ appears so often in protocols, regulatory submissions, and monitoring plans as effectively one term with two regional names. The distinction is administrative and jurisdictional, not functional.

Why two different terms exist

• IRB (Institutional Review Board): the term used in the United States, rooted in the Common Rule (45 CFR 46) for federally funded/conducted research and FDA’s parallel human-subjects regulations (21 CFR Part 56) for FDA-regulated trials. US IRBs must be registered with the Office for Human Research Protections (OHRP) and are typically named on an institution’s Federalwide Assurance (FWA).
• IEC (Independent Ethics Committee): the term used broadly outside the US, and the one ICH E6 uses as the generic label for the non-US equivalent body. Individual countries frequently use their own local name for the same function rather than the literal words “Independent Ethics Committee” — for example, the United Kingdom’s Health Research Authority oversees Research Ethics Committees (RECs), and Germany’s are commonly called Ethikkommissionen. CASRAI’s guide to the IRB/REC approval process covers what these committees review and what’s typically exempt, regardless of which regional name applies.

What stays constant across both terms

Whatever a given country calls its ethics-review body, ICH E6 GCP expects the same core safeguards: independence from the investigator and sponsor, a membership that includes at least one member whose primary area of interest is non-scientific and at least one member who is not affiliated with the institution/trial site, documented standard operating procedures, and a written approval (with the protocol version and date) before a site may begin enrolling participants. A trial that has “IRB/IEC approval” documented in its Trial Master File has met this requirement regardless of which regional name the approving body carries.

Where the terms genuinely diverge

The functional equivalence stops at the level of legal machinery. A US IRB operates under the Common Rule/FDA framework described above and is a single body of record for a given US site (or, under NIH’s single-IRB policy for qualifying multi-site domestic studies, for an entire US-based multi-site protocol). An IEC operates under whatever the host country’s own law provides — in the European Union, for instance, ethics review sits alongside, but is procedurally distinct from, the harmonized scientific/medical assessment that Regulation (EU) No 536/2014 coordinates across member states through the Clinical Trials Information System (CTIS): each member state’s ethics review remains a national competence, so a multinational EU trial still needs separate national ethics committee sign-off in every member state it runs in, even though the scientific dossier is assessed jointly. A sponsor running a trial across the US and multiple EU countries should expect to manage IRB/IEC approval as several genuinely separate national/institutional processes, not one.

Related CASRAI terms

• IRB (Institutional Review Board) — the US-specific term and regulatory framework.
• ICH E6(R2) — the GCP guideline that defines both IRB and IEC and sets the shared review standard.
• Independent Review Committee (IRC) — a differently-named, differently-functioned body (blinded endpoint re-review, e.g. in oncology imaging) that is easily confused with IEC by name alone but performs an unrelated role.
• IRB/REC Approval Process guide — what these committees review, and what is typically exempt.